Novartis Investigative Site

Dundee, Perthshire DD1 9SY

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Chronic Heart Failure With Reduced Ejection Fraction, Chronic Plaque Type Psoriasis, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early